Sources indicate Sakana AI is targeting an IPO in autumn 2027 and has appointed Goldman Sachs as advisor.

According to Nikkei Asia, Japan's Sakana AI lab plans its IPO for the fall of 2027 and has appointed Goldman Sachs as its advisor. It aims to become the first Japanese GenAI developer to list on a stock exchange. The company raised $4 billion in its Series B round in November 2025 at a valuation of 4 trillion yen, is developing its own Sawara series models, and plans to launch a smaller version in the spring of 2027.